» Articles » PMID: 34960067

Development of a 3D-Printed High Temperature Resin Cecal Fistula Implant for Long-Term and Minimally Invasive Access to the Gut Microbiome

Overview
Journal Nutrients
Date 2021 Dec 28
PMID 34960067
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Microbiota dysbiosis has been associated with chronic diseases ranging from gastrointestinal inflammatory and metabolic conditions to neurological changes affecting the gut-brain neural axis, mental health, and general well-being. However, current animal studies using oral gavage and gnotobiotic animals do not allow for non-invasive long-term access to gut microbiome. The purpose of the present study was to evaluate the feasibility of 3D-printed fistula implants through the body wall and into the cecum of rats to obtain long-term access to gut microbiome. Cecal fistulas were designed and 3D-printed using a high temperature resin (Formlabs; acrylic and methacrylic mixture). Nine male Sprague-Dawley rats underwent the fistula implantation. Food intake, body weight, and body fat were measured to determine the impact of fistula manipulation. Gut microbiome, vagal afferents in the hindbrain, and microglia activation were analyzed to determine if fistula implantation disrupted the gut-brain neural axis. We found that the procedure induced a transient decrease in microbial diversity in the gut that resolved within a few weeks. Fistula implantation had no impact on food intake, body weight, fat mass, or microglia activation. Our study shows that 3D-printed cecal fistula implantation is an effective procedure that allows long-term and minimally invasive access to gut microbiome.

Citing Articles

New Insights into the Gut Microbiota in Neurodegenerative Diseases from the Perspective of Redox Homeostasis.

Wang Y, Zhang Z, Li B, He B, Li L, Nice E Antioxidants (Basel). 2022; 11(11).

PMID: 36421473 PMC: 9687622. DOI: 10.3390/antiox11112287.


Clinical Potential of Microbial Strains, Used in Fermentation for Probiotic Food, Beverages and in Synbiotic Supplements, as Psychobiotics for Cognitive Treatment through Gut-Brain Signaling.

Dahiya D, Nigam P Microorganisms. 2022; 10(9).

PMID: 36144289 PMC: 9505539. DOI: 10.3390/microorganisms10091687.

References
1.
Zhang P, Yu Y, Qin Y, Zhou Y, Tang R, Wang Q . Alterations to the microbiota-colon-brain axis in high-fat-diet-induced obese mice compared to diet-resistant mice. J Nutr Biochem. 2019; 65:54-65. DOI: 10.1016/j.jnutbio.2018.08.016. View

2.
Banasaz M, Norin E, Holma R, Midtvedt T . Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol. 2002; 68(6):3031-4. PMC: 123962. DOI: 10.1128/AEM.68.6.3031-3034.2002. View

3.
Garrett W . Cancer and the microbiota. Science. 2015; 348(6230):80-6. PMC: 5535753. DOI: 10.1126/science.aaa4972. View

4.
Manichanh C, Reeder J, Gibert P, Varela E, Llopis M, Antolin M . Reshaping the gut microbiome with bacterial transplantation and antibiotic intake. Genome Res. 2010; 20(10):1411-9. PMC: 2945190. DOI: 10.1101/gr.107987.110. View

5.
Sartor R . Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008; 134(2):577-94. DOI: 10.1053/j.gastro.2007.11.059. View